Search Results 511-520 of 14847 for anti-TNF drugs

1. A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL) - Mayo Clinic

   A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin ...

2. Decongestant And Analgesic Combinations (Oral Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

3. Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide (Oral Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Genvoya. Descriptions. Elvitegravir, cobicistat ...

4. Chlorpheniramine, Ibuprofen, And Phenylephrine (Oral Route) Description and Brand Names - Mayo Clinic

   Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that is used in this combination to relieve inflammation, swelling, and pain. This medicine is ...

5. Antiviral Drugs and COVID-19 - Drug Discovery, Design and Optimization for Novel Therapeutics: Thomas Caulfield - Mayo Clinic Research

   Dr. Caulfield's Drug Discovery, Design and Optimization for Novel Therapeutics Lab at Mayo Clinic studies how to prevent viruses from binding, entering and ...

6. Mayo Clinic launches Cardiac Sarcoidosis Clinic

   Drugs & Supplements · Healthy ... TNF-inhibition with either infliximab or adalimumab should be considered. ... anti-arrhythmic therapy. VT recurrences are ...

7. Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic FSGS - Mayo Clinic

   ... medications for Crohn's disease therapy -Prior treatment failure or intolerance with at least one Anti Tumor Necrosis Factor-Alpha Therapy (anti-TNF α) agent.

8. An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease - Mayo Clinic

   This is an investigational study, also known as LATTICE-CD, of the experimental medication BMS-986165 in participants with moderate to severe Crohn's Disease, a ...

9. Testosterone (Transdermal Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

10. A Study to Evaluate the Safety, Effectiveness and Microbiological Response of Orally Administered ABI-M201 in Subjects with Mildly-to-Moderately Active Ulcerative Colitis with Ongoing Mesalamine Treatment - Mayo Clinic

    To evaluate a new oral treatment, ABI-M201 (or placebo) in individuals with mild to moderate Ulcerative Colitis who have sustained an inadequate response to ...